Original Article

Efficacy of Saffron Capsules on Binge Eating Episodes, Appetite and Body Mass Index of Individuals with Binge Eating Disorder: A 12-Week Randomized Clinical Trial

Abstract

Objective: We aimed to assess the efficacy of saffron versus placebo on binge eating severity, appetite, and body mass index (BMI) in adults diagnosed with binge eating disorder (BED).

Method: This was a 12-week randomized, double-blind, placebo-controlled trial with parallel design. We randomized 59 participants with confirmed diagnoses of BED according to DSM-5 criteria to receive either saffron extract (15 mg per capsule twice daily; total daily dose 30 mg; n = 30) or placebo (15 mg starch per capsule twice daily; n = 29). We assessed binge eating episodes (daily diary), appetite (visual analogue scale [VAS]), BMI, and macronutrient intake (3-day food records) before and after the trial. We analyzed the data using the intention-to-treat (ITT) approach and paired t-tests/Wilcoxon tests for within-group changes and independent t-tests/Mann-Whitney U tests for between-group differences. Furthermore, we used analysis of covariance (ANCOVA) with the primary outcome as the dependent variable and key baseline variables as covariates to compare endpoint outcomes between groups.

Results: We detected significant reductions in the saffron group compared with the placebo group in binge eating severity (mean difference: −1.16 ± 0.25; P ≤ 0.001; Cohen’s d = −1.30), Appetite VAS scores (−3.34 ± 0.56; P ≤ 0.001; Cohen’s d = −1.76), Calorie intake (−448 ± 113 kcal/day; P ≤ 0.001; Cohen’s d = −1.03), and Fat intake (−21.45 ± 5.10 g/day; P ≤ 0.001; Cohen’s d = −1.09). Furthermore, the saffron group showed a significant decrease in mean difference of BMI (−0.61 ± 0.45 kg/m²; P = 0.006; Cohen’s d = −0.43). ANCOVA results revealed that the adjusted treatment effect was -1.10 (95% CI: -1.60 to -0.60, P < 0.001).

Conclusion: Saffron supplementation significantly decreases the core symptoms of BED, reduces appetite and caloric intake, and modestly lowers BMI. Saffron capsules could be considered a safe and efficient supplement for people undergoing BED treatment.

1. Mustelin L, Raevuori A, Hoek HW, Kaprio J, Keski-Rahkonen A. Incidence and weight trajectories of binge eating disorder among young women in the community. Int J Eat Disord. 2015;48(8):1106-12.
2. Costandache GI, Munteanu O, Salaru A, Oroian B, Cozmin M. An overview of the treatment of eating disorders in adults and adolescents: pharmacology and psychotherapy. Postep Psychiatr Neurol. 2023;32(1):40-8.
3. Sadock BJ, Sadock VA, Ruiz P. Kaplan and Sadock's comprehensive textbook of psychiatry: lippincott Williams & wilkins; 2017.
4. Mohammadi MR, Mostafavi SA, Hooshyari Z, Khaleghi A, Ahmadi N, Molavi P, et al. Prevalence, correlates and comorbidities of feeding and eating disorders in a nationally representative sample of Iranian children and adolescents. Int J Eat Disord. 2020;53(3):349-61.
5. Grilo CM, Juarascio A. Binge-Eating Disorder Interventions: Review, Current Status, and Implications. Curr Obes Rep. 2023;12(3):406-16.
6. Smith KE, Goldschmidt AB. Treatment of Binge-Eating Disorder Across the Lifespan: An Updated Review of the Literature and Considerations for Future Research. Curr Obes Rep. 2024;13(2):195-202.
7. Grilo CM, Ivezaj V, Tek C, Yurkow S, Wiedemann AA, Gueorguieva R. Cognitive Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge-Eating Disorder with Obesity: A Randomized Controlled Trial. Am J Psychiatry. 2025;182(2):209-18.
8. Reas DL, Grilo CM. Current and emerging drug treatments for binge eating disorder. Expert Opin Emerg Drugs. 2014;19(1):99-142.
9. Hilbert A, Petroff D, Herpertz S, Pietrowsky R, Tuschen-Caffier B, Vocks S, et al. Meta-analysis on the long-term effectiveness of psychological and medical treatments for binge-eating disorder. Int J Eat Disord. 2020;53(9):1353-76.
10. Hilbert A, Petroff D, Herpertz S, Pietrowsky R, Tuschen-Caffier B, Vocks S, et al. Meta-analysis on the long-term effectiveness of psychological and medical treatments for binge-eating disorder. Int J Eat Disord. 2020;53(9):1353-76.
11. Rahmani J, Manzari N, Thompson J, Clark CCT, Villanueva G, Varkaneh HK, et al. The effect of saffron on weight and lipid profile: A systematic review, meta-analysis, and dose-response of randomized clinical trials. Phytother Res. 2019;33(9):2244-55.
12. Mohammadi MR, Akhondzadeh S, Keshavarz SA, Mostafavi SA. The Characteristics, Reliability and Validity of the Persian Version of Simplified Nutritional Appetite Questionnaire (SNAQ). J Nutr Health Aging. 2019;23(9):837-42.
13. Walker JL, Bell KL, Boyd RN, Davies PS. Validation of a modified three-day weighed food record for measuring energy intake in preschool-aged children with cerebral palsy. Clin Nutr. 2013;32(3):426-31.
14. Lu C, Ke L, Li J, Zhao H, Lu T, Mentis AFA, et al. Saffron (Crocus sativus L.) and health outcomes: a meta-research review of meta-analyses and an evidence mapping study. Phytomedicine. 2021; 91:153699.
15. Roshanravan B, Samarghandian S, Ashrafizadeh M, Amirabadizadeh A, Saeedi F, Farkhondeh T. Metabolic impact of saffron and crocin: an updated systematic and meta-analysis of randomised clinical trials. Arch Physiol Biochem. 2022;128(3):666-78.
16. Mashmoul M, Azlan A, Khaza'ai H, Yusof BN, Noor SM. Saffron: A Natural Potent Antioxidant as a Promising Anti-Obesity Drug. Antioxidants (Basel). 2013;2(4):293-308.
17. Razavi BM, Hosseinzadeh H. Saffron: a promising natural medicine in the treatment of metabolic syndrome. J Sci Food Agric. 2017;97(6):1679-85.
18. Ghaffari S, Roshanravan N. Saffron; An updated review on biological properties with special focus on cardiovascular effects. Biomed Pharmacother. 2019; 109:21-7.
19. Kamalipour M, Akhondzadeh S. Cardiovascular effects of saffron: an evidence-based review. J Tehran Heart Cent. 2011;6(2):59-61.
20. Ivezaj V, White MA, Grilo CM. Examining binge-eating disorder and food addiction in adults with overweight and obesity. Obesity (Silver Spring). 2016;24(10):2064-9.
21. Ryan DH, Yockey SR. Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over. Curr Obes Rep. 2017;6(2):187-94.
22. Ahmadikhatir S, Ostadrahimi A, Safaiyan A, Ahmadikhatir S, Farrin N. Saffron (Crocus sativus L.) supplements improve quality of life and appetite in atherosclerosis patients: A randomized clinical trial. J Res Med Sci. 2022; 27:30.
23. Hausenblas HA, Heekin K, Mutchie HL, Anton S. A systematic review of randomized controlled trials examining the effectiveness of saffron (Crocus sativus L.) on psychological and behavioral outcomes. J Integr Med. 2015;13(4):231-40.
24. Kumar V, Kaur N, Wadhwa P. Clinical evidence on the effects of saffron (Crocus sativus L.) in anxiety and depression. World J Tradit Chin Med. 2022;8(2):181-7.
25. Kamalipour M, Jamshidi A, Akhoundzadeh S. Antidepressant effect of Crocus sativus: An evidence based review. 2010.
26. Esalatmanesh S, Biuseh M, Noorbala AA, Mostafavi SA, Rezaei F, Mesgarpour B, et al. Comparison of Saffron and Fluvoxamine in the Treatment of Mild to Moderate Obsessive-Compulsive Disorder: A Double Blind Randomized Clinical Trial. Iran J Psychiatry. 2017;12(3):154-62.
27. Akhondzadeh S, Mostafavi SA, Keshavarz SA, Mohammadi MR, Hosseini S, Eshraghian MR. A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression. J Clin Pharm Ther. 2020;45(1):134-43.
28. Mashmoul M, Azlan A, Mohtarrudin N, Yusof BNM, Khaza'ai H. Saffron Extract and Crocin Reduced Biomarkers Associated with Obesity in Rats Fed a High-Fat Diet. Malays J Nutr. 2017;23(1):117.
29. Lai Z, Cao Y, Zhang Y, Cai Y, Zhang S, Li Y, et al. The antidepressant potential of saffron (Crocus sativus L.): molecular mechanisms, neurotransmitter modulation, gut-brain axis interactions, and clinical efficacy in major depressive disorder. Phytochem Rev. 2026;25(1):273-304.
30. Monchaux De Oliveira C, Pourtau L, Vancassel S, Pouchieu C, Capuron L, Gaudout D, et al. Saffron Extract-Induced Improvement of Depressive-Like Behavior in Mice Is Associated with Modulation of Monoaminergic Neurotransmission. Nutrients. 2021;13(3).
31. Gout B, Bourges C, Paineau-Dubreuil S. Satiereal, a Crocus sativus L extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women. Nutr Res. 2010;30(5):305-13.
32. Liu Y, Sun M, Yao H, Liu Y, Gao R. Herbal medicine for the treatment of obesity: an overview of scientific evidence from 2007 to 2017. Evidence‐Based Complementary and Alternative Medicine. 2017;2017(1):8943059.
Files
IssueVol 21 No 4 (2026) QRcode
SectionOriginal Article(s)
Keywords
Appetite Body Mass Index(BMI) Binge-Eating Disorder Dietary Intake Randomized Controlled Trial Saffron
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Amiri S, Mostafavi S-A, Noorbala AA, Karkhaneh Yousefi A, Akhondzadeh S. Efficacy of Saffron Capsules on Binge Eating Episodes, Appetite and Body Mass Index of Individuals with Binge Eating Disorder: A 12-Week Randomized Clinical Trial. Iran J Psychiatry. 2026;21(4):477-487.